Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (45)
  • 2024 (26)
  • 2023 (47)
  • 2022 (136)
  • 2021 (162)
  • 2020 (53)
  • 2019 (75)
  • 2018 (41)
  • 2017 (37)
  • 2016 (47)
  • 2015 (42)
  • 2014 (54)
  • 2013 (64)
  • 2012 (18)
  • 2011 (67)
  • 2008 (10)
  • 2007 (18)
  • 2006 (23)
  • 2005 (15)
  • 2004 (13)
  • 2003 (23)

Subject

  • Drug Trafficking (240)
  • Synthetic drugs (190)
  • Seizures (Drugs/Property) (184)
  • Task Forces/Task Force Officers (168)
  • Major Law Enforcement Operation (137)
  • Guns/Weapons (103)
  • OCDETF/Task Force (86)
  • Overdose (71)
  • Arrests/Convictions - Major (67)
  • Prescription Drugs (66)
  • Fake Pills (63)
  • Gangs (51)
  • Outreach/Drug Prevention (49)
  • Pharmaceuticals/Pharmacists/Physicians (44)
  • Diversion Division (42)
  • Narcoterrorism (41)
  • Take Back Day (36)
  • Press Conferences (32)
  • Guilty Plea (31)
  • Public and Media Affairs - also see Congressional Affairs (26)
  • Money Laundering (23)
  • One Pill Can Kill (18)
  • Fentanyl Awareness (17)
  • Prevention/Education - DEA websites GSAD, JTT etc (15)
  • Congressional Affairs (12)
  • HIDTA (10)
  • International/Foreign Operations (10)
  • Red Ribbon (9)
  • Dark Web- Internet Trafficking (8)
  • Extraditions (7)
  • Intergovernmental Affairs (6)
  • Asset Forfeiture (5)
  • Critical Incident (3)
  • Museum and Visitors Center (3)
  • Terrorism (3)
  • Fentanyl Free America (2)
  • Intelligence Division - Intelligence Products (2)
  • Scam Calls (2)
  • Campaigns (1)
  • Counterfeit Pills (1)
  • Other (1)

Drug Name

  • Fentanyl (195)
  • Cocaine (138)
  • Heroin (107)
  • Synthetic Opioids (89)
  • Methamphetamine (73)
  • Opioids (60)
  • Oxycodone (28)
  • Marijuana (Cannabis) (21)
  • Hydromorphone (7)
  • Benzodiazepines (6)
  • Ecstasy/MDMA (5)
  • Morphine (5)
  • K2/Spice (4)
  • Steroids (4)
  • Marijuana Concentrates (3)
  • Ketamine (2)
  • Methadone (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • Amphetamines (1)
  • GHB (1)
  • Psilocybin (1)
  • Xylazine (1)

Field Division

  • New England (2349)
  • New York (1519)
  • Houston (893)
  • San Francisco (842)
  • Miami (826)
  • St. Louis (808)
  • Seattle (801)
  • Atlanta (763)
  • Chicago (622)
  • New Jersey (493)
  • New Orleans (470)
  • Detroit (360)
  • El Paso (346)
  • Dallas (315)
  • Los Angeles (299)
  • Phoenix (272)
  • San Diego (244)
  • Rocky Mountain (165)
  • Philadelphia (140)
  • Omaha (134)
  • Caribe (79)
  • Louisville (78)
  • Caribe (1)
  • Washington, DC (613)
  • Sede (408)
Clear All Results
PRESS RELEASE

DEA and partners hold National Prescription Drug Take Back Day on October 27

Octubre 22, 2018
WASHINGTON – After collecting a total of more than 9.9 million pounds (nearly 5,000 tons) of expired, unused and unwanted prescription medications during 15 previous events over the past eight years, the Drug Enforcement Administration expects to reach a total of 10 million pounds collected following the upcoming fall 2018...
Octubre 22, 2018
PRESS RELEASE

DEA to kick off annual Red Ribbon Campaign

Octubre 16, 2018
WASHINGTON – The United States Drug Enforcement Administration is gearing up to kick off its annual Red Ribbon Campaign, the nation’s largest drug prevention effort, which launches October 23. The National Red Ribbon Campaign began after drug traffickers in Mexico tortured and brutally murdered Special Agent Enrique “Kiki” Camarena in...
Octubre 16, 2018
PRESS RELEASE

Justice, Treasury, and State Departments announce coordinated enforcement efforts against Cartel Jalisco Nueva Generacion

Octubre 16, 2018
WASHINGTON – The United States of America, through its Departments of Justice, Treasury, and State announced today a series of measures to target and dismantle the Cartel Jalisco Nueva Generacion (CJNG) – one of the largest, most dangerous drug cartels currently operating in Mexico. These measures include the unsealing of...
Octubre 16, 2018
PRESS RELEASE

DEA Acting Administrator underscores the importance of drug enforcement efforts to combat opioid epidemic

Octubre 12, 2018
SALT LAKE CITY – DEA Acting Administrator Uttam Dhillon today highlighted the significance of law enforcement as part of a successful, comprehensive solution to the opioid epidemic, stressing efforts aimed at those supplying communities with deadly, addictive drugs. Acting Administrator Dhillon delivered remarks to hundreds of medical practitioners, drug treatment...
Octubre 12, 2018
PRESS RELEASE

DEA joins HHS, ONDCP for listening session with nationwide drug prescribers to discuss concerns and solutions

Octubre 04, 2018
WASHINGTON – DEA’s head of Diversion Control today joined with senior Department of Health & Human Services and Office of National Drug Control Policy officials to host a listening session with health care provider groups who represent drug prescribers nationwide. The purpose of the summit was to hear concerns and...
Octubre 04, 2018
PRESS RELEASE

FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act

Septiembre 27, 2018
WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...
Septiembre 27, 2018
PRESS RELEASE

Two Afghan heroin traffickers sentenced in Manhattan federal court for conspiring to import heroin into the United States

Septiembre 18, 2018
NEW YORK – Raymond P. Donovan, Special Agent in Charge of the U.S. Drug Enforcement Administration’s Special Operations Division, along with Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced that Lajbar Lajaward Khan, aka “Haji Lajaward,” and Amal Said Said Alam Shah, aka...
Septiembre 18, 2018
PRESS RELEASE

Maryland MS-13 program leader pleads guilty

Septiembre 07, 2018
Washington D.C. – Jose Augustin Salmeron-Larios aka "Joseph Morales-Martinez," "Angel Salvador Gutierrez," "Yankee," and "Kean," age 25, of Severn, Maryland, pleaded guilty today to a conspiracy to participate in a racketeering enterprise known as La Mara Salvatrucha, or MS-13; attempted murder in aid of racketeering; and using and carrying a...
Septiembre 07, 2018
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

Agosto 31, 2018
WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
Agosto 31, 2018
PRESS RELEASE

Justice Department announces release of new fentanyl safety video for first responders

Agosto 30, 2018
WASHINGTON – The Office of Justice Programs’ Bureau of Justice Assistance today released the Fentanyl Safety Recommendations for First Responders’ companion training video Fentanyl: The Real Deal. The video was produced by U.S. Customs and Border Protection to help first responders protect themselves when the presence of fentanyl is suspected...
Agosto 30, 2018
Showing 551 - 560 of 1016 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 52
  • Página 53
  • Página 54
  • Página 55
  • Current page 56
  • Página 57
  • Página 58
  • Página 59
  • Página 60
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster